研究园简易版 · 经典书籍 · 期刊文章 · 有原文 · 完整版(可多选筛选、搜索) · 首页
2017 年的期刊文章 · 第 21 页
共 1233 篇,按发表时间排,新的在前,每页 40 篇。这一页是 2017-03-15 到 2017-02-24。
按期刊、按主题看 →
SiM Survival Analysis · 发表于 2017-03-15
Adam R. Brentnall, Peter Sasieni, Jack Cuzick
摘要
When one arm in a trial has a worse early endpoint such as recurrence, a data-monitoring committee might recommend that all participants are offered the apparently superior treatment. The resultant crossover makes it difficult to measure differences between arms thereafter, including for longer-term endpoints such as mortality and disease-specific mortality. In this paper, we consider estimators of the efficacy of treatment on those who would not cross over if randomised to the apparently inferior arm. Binomial and proportional hazards maximum likelihood estimators are developed. The binomial estimator is applied to analysis of a breast cancer treatment trial and compared with intention-to-treat and inverse probability weighting estimators. Full and partial likelihood proportional-hazard model estimators are assessed through computer simulations, where they had similar bias and variance. The new efficacy estimators extend those for all-or-none compliance to this important problem. © 2017 The Authors. Statistics in Medicine Published by John Wiley & Sons Ltd. *(abstract via PubMed)*
SMMR Clinical Trials · 发表于 2017-03-14
Marius Placzek, Tim Friede
摘要
The importance of subgroup analyses has been increasing due to a growing interest in personalized medicine and targeted therapies. Considering designs with multiple nested subgroups and a continuous endpoint, we develop methods for the analysis and sample size determination. First, we consider the joint distribution of standardized test statistics that correspond to each (sub)population. We derive multivariate exact distributions where possible, providing approximations otherwise. Based on these results, we present sample size calculation procedures. Uncertainties about nuisance parameters which are needed for sample size calculations make the study prone to misspecifications. We discuss how a sample size review can be performed in order to make the study more robust. To this end, we implement an internal pilot study design where the variances and prevalences of the subgroups are reestimated in a blinded fashion and the sample size is recalculated accordingly. Simulations show that the procedures presented here do not inflate the type I error significantly and maintain the prespecified power as long as the sample size of the smallest subgroup is not too small. We pay special attention to the case of small sample sizes and attain a lower boundary for the size of the internal pilot study.
SiM Missing Data & Measurement Error · 发表于 2017-03-14
Susan M. Shortreed, Eric Laber, T. Scott Stroup, Joelle Pineau, Susan A. Murphy
摘要
The code and example data set had been added as supporting information for this paper 1 and can be downloaded at: http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.6223/suppinfo. *(abstract via OpenAlex)*
SMMR Other · 发表于 2017-03-13
Robert G Clark, Margo Barr
摘要
A binary health outcome may be regressed on covariates using a log link, rather than more typical link functions such as the logit. This allows the exponentiated regression coefficient for each covariate to be interpreted as a relative risk conditional on the remaining covariates. Relative risks are simpler to interpret than the odds ratios which arise with a logit link. There are practical and conceptual challenges in log-link binary regression, mainly due to the requirement that probabilities are less than or equal to 1. Viable probabilities are now usually achieved by the imposition of a constraint on the parameter space, but the log link function is still more work to apply in practice. We propose instead a new smooth link function which is equal to the log up to a cutoff and a linearly scaled logit function above the cutoff. The new approach is conceptually clearer, simpler to implement and generally less biased, and it retains the relative risk interpretation for all but the highest risk individuals. Alternative binary regressions are compared using a simulation study and a diabetic retinopathy dataset.
SiM High-Dimensional · 发表于 2017-03-12
Rainer Puhr, Georg Heinze, Mariana Nold, Lara Lusa, Angelika Geroldinger
摘要
Firth's logistic regression has become a standard approach for the analysis of binary outcomes with small samples. Whereas it reduces the bias in maximum likelihood estimates of coefficients, bias towards one‐half is introduced in the predicted probabilities. The stronger the imbalance of the outcome, the more severe is the bias in the predicted probabilities. We propose two simple modifications of Firth's logistic regression resulting in unbiased predicted probabilities. The first corrects the predicted probabilities by a post hoc adjustment of the intercept. The other is based on an alternative formulation of Firth's penalization as an iterative data augmentation procedure. Our suggested modification consists in introducing an indicator variable that distinguishes between original and pseudo‐observations in the augmented data. In a comprehensive simulation study, these approaches are compared with other attempts to improve predictions based on Firth's penalization and to other published penalization strategies intended for routine use. For instance, we consider a recently suggested compromise between maximum likelihood and Firth's logistic regression. Simulation results are scrutinized with regard to prediction and effect estimation. We find that both our suggested methods do not only give unbiased predicted probabilities but also improve the accuracy conditional on explanatory variables compared with Firth's penalization. While one method results in effect estimates identical to those of Firth's penalization, the other introduces some bias, but this is compensated by a decrease in the mean squared error. Finally, all methods considered are illustrated and compared for a study on arterial closure devices in minimally invasive cardiac surgery. Copyright © 2017 John Wiley & Sons, Ltd.
SiM Bayesian Methods · 发表于 2017-03-12
Longhai Li, Cindy X. Feng, Shi Qiu
摘要
An important statistical task in disease mapping problems is to identify divergent regions with unusually high or low risk of disease. Leave‐one‐out cross‐validatory (LOOCV) model assessment is the gold standard for estimating predictive p‐values that can flag such divergent regions. However, actual LOOCV is time‐consuming because one needs to rerun a Markov chain Monte Carlo analysis for each posterior distribution in which an observation is held out as a test case. This paper introduces a new method, called integrated importance sampling (iIS), for estimating LOOCV predictive p‐values with only Markov chain samples drawn from the posterior based on a full data set. The key step in iIS is that we integrate away the latent variables associated the test observation with respect to their conditional distribution without reference to the actual observation. By following the general theory for importance sampling, the formula used by iIS can be proved to be equivalent to the LOOCV predictive p‐value. We compare iIS and other three existing methods in the literature with two disease mapping datasets. Our empirical results show that the predictive p‐values estimated with iIS are almost identical to the predictive p‐values estimated with actual LOOCV and outperform those given by the existing three methods, namely, the posterior predictive checking, the ordinary importance sampling, and the ghosting method by Marshall and Spiegelhalter (2003). Copyright © 2017 John Wiley & Sons, Ltd.
Biometrics Functional Data · 发表于 2017-03-10
Peijun Sang, Liangliang Wang, Jiguo Cao
摘要
Summary: Functional principal component analysis (FPCA) is a popular approach in functional data analysis to explore major sources of variation in a sample of random curves. These major sources of variation are represented by functional principal components (FPCs). Most existing FPCA approaches use a set of flexible basis functions such as B-spline basis to represent the FPCs, and control the smoothness of the FPCs by adding roughness penalties. However, the flexible representations pose difficulties for users to understand and interpret the FPCs. In this article, we consider a variety of applications of FPCA and find that, in many situations, the shapes of top FPCs are simple enough to be approximated using simple parametric functions. We propose a parametric approach to estimate the top FPCs to enhance their interpretability for users. Our parametric approach can also circumvent the smoothing parameter selecting process in conventional nonparametric FPCA methods. In addition, our simulation study shows that the proposed parametric FPCA is more robust when outlier curves exist. The parametric FPCA method is demonstrated by analyzing several datasets from a variety of applications.
Biometrics Networks & Graphs Genetics & Omics · 发表于 2017-03-10
Bochao Jia, Suwa Xu, Guanghua Xiao, Vishal Lamba, Faming Liang
摘要
Summary: In recent years, next generation sequencing (NGS) has gradually replaced microarray as the major platform in measuring gene expressions. Compared to microarray, NGS has many advantages, such as less noise and higher throughput. However, the discreteness of NGS data also challenges the existing statistical methodology. In particular, there still lacks an appropriate statistical method for reconstructing gene regulatory networks using NGS data in the literature. The existing local Poisson graphical model method is not consistent and can only infer certain local structures of the network. In this article, we propose a random effect model-based transformation to continuize NGS data and then we transform the continuized data to Gaussian via a semiparametric transformation and apply an equivalent partial correlation selection method to reconstruct gene regulatory networks. The proposed method is consistent. The numerical results indicate that the proposed method can lead to much more accurate inference of gene regulatory networks than the local Poisson graphical model and other existing methods. The proposed data-continuized transformation fills the theoretical gap for how to transform discrete data to continuous data and facilitates NGS data analysis. The proposed data-continuized transformation also makes it feasible to integrate different types of data, such as microarray and RNA-seq data, in reconstruction of gene regulatory networks.
SiM Longitudinal Data Survival Analysis · 发表于 2017-03-10
K. Maruo, Y. Yamaguchi, H. Noma, M. Gosho
摘要
We derived results for inference on parameters of the marginal model of the mixed effect model with the Box-Cox transformation based on the asymptotic theory approach. We also provided a robust variance estimator of the maximum likelihood estimator of the parameters of this model in consideration of the model misspecifications. Using these results, we developed an inference procedure for the difference of the model median between treatment groups at the specified occasion in the context of mixed effects models for repeated measures analysis for randomized clinical trials, which provided interpretable estimates of the treatment effect. From simulation studies, it was shown that our proposed method controlled type I error of the statistical test for the model median difference in almost all the situations and had moderate or high performance for power compared with the existing methods. We illustrated our method with cluster of differentiation 4 (CD4) data in an AIDS clinical trial, where the interpretability of the analysis results based on our proposed method is demonstrated. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
Biometrics Testing & Uncertainty Functional Data · 发表于 2017-03-10
Yu-Ru Su, Chong-Zhi Di, Li Hsu
摘要
Summary: Functional data arise frequently in biomedical studies, where it is often of interest to investigate the association between functional predictors and a scalar response variable. While functional linear models (FLM) are widely used to address these questions, hypothesis testing for the functional association in the FLM framework remains challenging. A popular approach to testing the functional effects is through dimension reduction by functional principal component (PC) analysis. However, its power performance depends on the choice of the number of PCs, and is not systematically studied. In this article, we first investigate the power performance of the Wald-type test with varying thresholds in selecting the number of PCs for the functional covariates, and show that the power is sensitive to the choice of thresholds. To circumvent the issue, we propose a new method of ordering and selecting principal components to construct test statistics. The proposed method takes into account both the association with the response and the variation along each eigenfunction. We establish its theoretical properties and assess the finite sample properties through simulations. Our simulation results show that the proposed test is more robust against the choice of threshold while being as powerful as, and often more powerful than, the existing method. We then apply the proposed method to the cerebral white matter tracts data obtained from a diffusion tensor imaging tractography study.
Biometrics Survival Analysis Diagnostics & Prediction · 发表于 2017-03-10
Yu Zheng, Tianxi Cai
摘要
Summary: Reliable and accurate risk prediction is fundamental for successful management of clinical conditions. Estimating comprehensive risk prediction models precisely, however, is a difficult task, especially when the outcome of interest is time to a rare event and the number of candidate predictors, p, is not very small. Another challenge in developing accurate risk models arises from potential model misspecification. Time-specific generalized linear models estimated with inverse censoring probability weighting are robust to model misspecification, but may be inefficient in the rare event setting. To improve the efficiency of such robust estimation procedures, various augmentation methods have been proposed in the literature. These procedures can also leverage auxiliary variables such as intermediate outcomes that are predictive of event risk. However, most existing methods do not perform well in the rare event setting, especially when p is not small. In this article, we propose a two-step, imputation-based augmentation procedure that can improve estimation efficiency and that is robust to model misspecification. We also develop regularized augmentation procedures for settings where p is not small, along with procedures to improve the estimation of individualized treatment effect in risk reduction. Numerical studies suggest that our proposed methods substantially outperform existing methods in efficiency gains. The proposed methods are applied to an AIDS clinical trial for treating HIV-infected patients.
Biometrics Genetics & Omics Nonparametric & Semiparametric · 发表于 2017-03-10
Xiang Zhan, Anna Plantinga, Ni Zhao, Michael C. Wu
摘要
Summary: To fully understand the role of microbiome in human health and diseases, researchers are increasingly interested in assessing the relationship between microbiome composition and host genomic data. The dimensionality of the data as well as complex relationships between microbiota and host genomics pose considerable challenges for analysis. In this article, we apply a kernel RV coefficient (KRV) test to evaluate the overall association between host gene expression and microbiome composition. The KRV statistic can capture nonlinear correlations and complex relationships among the individual data types and between gene expression and microbiome composition through measuring general dependency. Testing proceeds via a similar route as existing tests of the generalized RV coefficients and allows for rapid p-value calculation. Strategies to allow adjustment for confounding effects, which is crucial for avoiding misleading results, and to alleviate the problem of selecting the most favorable kernel are considered. Simulation studies show that KRV is useful in testing statistical independence with finite samples given the kernels are appropriately chosen, and can powerfully identify existing associations between microbiome composition and host genomic data while protecting type I error. We apply the KRV to a microbiome study examining the relationship between host transcriptome and microbiome composition within the context of inflammatory bowel disease and are able to derive new biological insights and provide formal inference on prior qualitative observations.
SiM Bayesian Methods · 发表于 2017-03-09
Siva. Sivaganesan, Peter Müller, Bin Huang
摘要
We provide a Bayesian decision theoretic approach to finding subgroups that have elevated treatment effects. Our approach separates the modeling of the response variable from the task of subgroup finding and allows a flexible modeling of the response variable irrespective of potential subgroups of interest. We use Bayesian additive regression trees to model the response variable and use a utility function defined in terms of a candidate subgroup and the predicted response for that subgroup. Subgroups are identified by maximizing the expected utility where the expectation is taken with respect to the posterior predictive distribution of the response, and the maximization is carried out over an a priori specified set of candidate subgroups. Our approach allows subgroups based on both quantitative and categorical covariates. We illustrate the approach using simulated data set study and a real data set. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Causal Inference · 发表于 2017-03-09
Emma Persson, Ingeborg Waernbaum, Torbjörn Lind
摘要
When an initial case-control study is performed, data can be used in a secondary analysis to evaluate the effect of the case-defining event on later outcomes. In this paper, we study the example in which the role of the event is changed from a response variable to a treatment of interest. If the aim is to estimate marginal effects, such as average effects in the population, the sampling scheme needs to be adjusted for. We study estimators of the average effect of the treatment in a secondary analysis of matched and unmatched case-control data where the probability of being a case is known. For a general class of estimators, we show the components of the bias resulting from ignoring the sampling scheme and demonstrate a design-weighted matching estimator of the average causal effect. In simulations, the finite sample properties of the design-weighted matching estimator are studied. Using a Swedish diabetes incidence register with a matched case-control design, we study the effect of childhood onset diabetes on the use of antidepressant medication as an adult. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Diagnostics & Prediction · 发表于 2017-03-09
Soyoung Kim, Ying Huang
摘要
Combining multiple markers can improve classification accuracy compared with using a single marker. In practice, covariates associated with markers or disease outcome can affect the performance of a biomarker or biomarker combination in the population. The covariate-adjusted receiver operating characteristic (ROC) curve has been proposed as a tool to tease out the covariate effect in the evaluation of a single marker; this curve characterizes the classification accuracy solely because of the marker of interest. However, research on the effect of covariates on the performance of marker combinations and on how to adjust for the covariate effect when combining markers is still lacking. In this article, we examine the effect of covariates on classification performance of linear marker combinations and propose to adjust for covariates in combining markers by maximizing the nonparametric estimate of the area under the covariate-adjusted ROC curve. The proposed method provides a way to estimate the best linear biomarker combination that is robust to risk model assumptions underlying alternative regression-model-based methods. The proposed estimator is shown to be consistent and asymptotically normally distributed. We conduct simulations to evaluate the performance of our estimator in cohort and case/control designs and compare several different weighting strategies during estimation with respect to efficiency. Our estimator is also compared with alternative regression-model-based estimators or estimators that maximize the empirical area under the ROC curve, with respect to bias and efficiency. We apply the proposed method to a biomarker study from an human immunodeficiency virus vaccine trial. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Clinical Trials Testing & Uncertainty Nonparametric & Semiparametric · 发表于 2017-03-09
Alok Kumar Dwivedi, Indika Mallawaarachchi, Luis A. Alvarado
摘要
Experimental studies in biomedical research frequently pose analytical problems related to small sample size. In such studies, there are conflicting findings regarding the choice of parametric and nonparametric analysis, especially with non‐normal data. In such instances, some methodologists questioned the validity of parametric tests and suggested nonparametric tests. In contrast, other methodologists found nonparametric tests to be too conservative and less powerful and thus preferred using parametric tests. Some researchers have recommended using a bootstrap test; however, this method also has small sample size limitation. We used a pooled method in nonparametric bootstrap test that may overcome the problem related with small samples in hypothesis testing. The present study compared nonparametric bootstrap test with pooled resampling method corresponding to parametric, nonparametric, and permutation tests through extensive simulations under various conditions and using real data examples. The nonparametric pooled bootstrapt‐test provided equal or greater power for comparing two means as compared with unpairedt‐test, Welcht‐test, Wilcoxon rank sum test, and permutation test while maintaining type I error probability for any conditions except for Cauchy and extreme variable lognormal distributions. In such cases, we suggest using an exact Wilcoxon rank sum test. Nonparametric bootstrap pairedt‐test also provided better performance than other alternatives. Nonparametric bootstrap test provided benefit over exact Kruskal–Wallis test. We suggest using nonparametric bootstrap test with pooled resampling method for comparing paired or unpaired means and for validating the one way analysis of variance test results for non‐normal data in small sample size studies. Copyright © 2017 John Wiley & Sons, Ltd.
Biometrics Genetics & Omics · 发表于 2017-03-08
Wei Dai, Ming Yang, Chaolong Wang, Tianxi Cai
摘要
Summary: Genome-wide association studies (GWAS) and next generation sequencing studies (NGSS) are often performed in family studies to improve power in identifying genetic variants that are associated with clinical phenotypes. Efficient analysis of genome-wide studies with familial data is challenging due to the difficulty in modeling shared but unmeasured genetic and/or environmental factors that cause dependencies among family members. Existing genetic association testing procedures for family studies largely rely on generalized estimating equations (GEE) or linear mixed-effects (LME) models. These procedures may fail to properly control for type I errors when the imposed model assumptions fail. In this article, we propose the Sequence Robust Association Test (SRAT), a fully rank-based, flexible approach that tests for association between a set of genetic variants and an outcome, while accounting for within-family correlation and adjusting for covariates. Comparing to existing methods, SRAT has the advantages of allowing for unknown correlation structures and weaker assumptions about the outcome distribution. We provide theoretical justifications for SRAT and show that SRAT includes the well-known Wilcoxon rank sum test as a special case. Extensive simulation studies suggest that SRAT provides better protection against type I error rate inflation, and could be much more powerful for settings with skewed outcome distribution than existing methods. For illustration, we also apply SRAT to the familial data from the Framingham Heart Study and Offspring Study to examine the association between an inflammatory marker and a few sets of genetic variants.
Biometrics Causal Inference High-Dimensional · 发表于 2017-03-08
Susan M. Shortreed, Ashkan Ertefaie
摘要
Summary: Methodological advancements, including propensity score methods, have resulted in improved unbiased estimation of treatment effects from observational data. Traditionally, a “throw in the kitchen sink” approach has been used to select covariates for inclusion into the propensity score, but recent work shows including unnecessary covariates can impact both the bias and statistical efficiency of propensity score estimators. In particular, the inclusion of covariates that impact exposure but not the outcome, can inflate standard errors without improving bias, while the inclusion of covariates associated with the outcome but unrelated to exposure can improve precision. We propose the outcome-adaptive lasso for selecting appropriate covariates for inclusion in propensity score models to account for confounding bias and maintaining statistical efficiency. This proposed approach can perform variable selection in the presence of a large number of spurious covariates, that is, covariates unrelated to outcome or exposure. We present theoretical and simulation results indicating that the outcome-adaptive lasso selects the propensity score model that includes all true confounders and predictors of outcome, while excluding other covariates. We illustrate covariate selection using the outcome-adaptive lasso, including comparison to alternative approaches, using simulated data and in a survey of patients using opioid therapy to manage chronic pain.
Biometrika Meta-Analysis & Data Integration · 发表于 2017-03-08
I. Kosmidis, A. Guolo, C. Varin
摘要
Summary: Random-effects models are frequently used to synthesize information from different studies in meta-analysis. While likelihood-based inference is attractive both in terms of limiting properties and of implementation, its application in random-effects meta-analysis may result in misleading conclusions, especially when the number of studies is small to moderate. The current paper shows how methodology that reduces the asymptotic bias of the maximum likelihood estimator of the variance component can also substantially improve inference about the mean effect size. The results are derived for the more general framework of random-effects meta-regression, which allows the mean effect size to vary with study-specific covariates.
SMMR Functional Data Testing & Uncertainty · 发表于 2017-03-03
Chunzheng Cao, Jian Qing Shi, Youngjo Lee
摘要
We introduce flexible robust functional regression models, using various heavy-tailed processes, including a Student t-process. We propose efficient algorithms in estimating parameters for the marginal mean inferences and in predicting conditional means as well as interpolation and extrapolation for the subject-specific inferences. We develop bootstrap prediction intervals (PIs) for conditional mean curves. Numerical studies show that the proposed model provides a robust approach against data contamination or distribution misspecification, and the proposed PIs maintain the nominal confidence levels. A real data application is presented as an illustrative example.
Biometrics Spatial & Time Series Survival Analysis Testing & Uncertainty · 发表于 2017-03-03
Yu Deng, Donglin Zeng, Jinying Zhao, Jianwen Cai
摘要
Summary: In many epidemiology studies, family data with survival endpoints are collected to investigate the association between risk factors and disease incidence. Sometimes the risk of the disease may change when a certain risk factor exceeds a certain threshold. Finding this threshold value could be important for disease risk prediction and diseases prevention. In this work, we propose a change-point proportional hazards model for clustered event data. The model incorporates the unknown threshold of a continuous variable as a change point in the regression. The marginal pseudo-partial likelihood functions are maximized for estimating the regression coefficients and the unknown change point. We develop a supremum test based on robust score statistics to test the existence of the change point. The inference for the change point is based on the m out of n bootstrap. We establish the consistency and asymptotic distributions of the proposed estimators. The finite-sample performance of the proposed method is demonstrated via extensive simulation studies. Finally, the Strong Heart Family Study dataset is analyzed to illustrate the methods.
Biometrics Other · 发表于 2017-03-03
Yakir Berchenko, Jonathan D. Rosenblatt, Simon D. W. Frost
摘要
Summary: Respondent-driven sampling (RDS) is an approach to sampling design and analysis which utilizes the networks of social relationships that connect members of the target population, using chain-referral. RDS sampling will typically oversample participants with many acquaintances. Naïve estimators, such as the sample average, will thus be biased towards the state of the most highly connected individuals. Current methodology cannot estimate population size from RDS, and promotes inverse probability weighted estimators for population parameters such as HIV prevalence. We propose to use the timing of recruitment, typically collected and discarded, in order to estimate the population size via a counting process model. Once population size and degree frequencies are made available, prevalence can be debiased in a post-stratified framework. We adapt methods developed for inference in epidemiology and software reliability to estimate the population size, degree counts and frequencies. A fundamental advantage of our approach is that it makes the assumptions of the sampling design explicit. This enables verification of the assumptions, maximum likelihood estimation, extension with covariates, and model selection. We develop large-sample theory, proving consistency and asymptotic normality. We further compare our estimators to other estimators in the RDS literature, through simulation and real-world data. In both cases, we find our estimators to outperform current methods. The likelihood problem in the model we present is separable, and thus efficiently solvable. We implement these estimators in an accompanying R package, chords, available on CRAN.
Biometrics Bayesian Methods Clinical Trials Diagnostics & Prediction · 发表于 2017-03-03
Satoshi Morita, Peter Müller
摘要
Summary: The identification of good predictive biomarkers allows investigators to optimize the target population for a new treatment. We propose a novel utility-based Bayesian population finding (BaPoFi) method to analyze data from a randomized clinical trial with the aim of finding a sensitive patient population. Our approach is based on casting the population finding process as a formal decision problem together with a flexible probability model, Bayesian additive regression trees (BART), to summarize observed data. The proposed method evaluates enhanced treatment effects in patient subpopulations based on counter-factual modeling of responses to new treatment and control for each patient. In extensive simulation studies, we examine the operating characteristics of the proposed method. We compare with a Bayesian regression-based method that implements shrinkage estimates of subgroup-specific treatment effects. For illustration, we apply the proposed method to data from a randomized clinical trial.
SMMR Other · 发表于 2017-03-03
Tsung-Shan Tsou
摘要
Pairing serves as a way of lessening heterogeneity but pays the price of introducing more parameters to the model. This complicates the probability structure and makes inference more intricate. We employ the simpler structure of the parallel design to develop a robust score statistic for testing the equality of two multinomial distributions in paired designs. This test incorporates the within-pair correlation in a data-driven manner without a full model specification. In the paired binary data scenario, the robust score statistic turns out to be the McNemar’s test. We provide simulations and real data analysis to demonstrate the advantage of the robust procedure.
SMMR Bayesian Methods Causal Inference · 发表于 2017-03-02
Alexander P Keil, Eric J Daza, Stephanie M Engel, Jessie P Buckley, Jessie K Edwards
摘要
Epidemiologists often wish to estimate quantities that are easy to communicate and correspond to the results of realistic public health interventions. Methods from causal inference can answer these questions. We adopt the language of potential outcomes under Rubin’s original Bayesian framework and show that the parametric g-formula is easily amenable to a Bayesian approach. We show that the frequentist properties of the Bayesian g-formula suggest it improves the accuracy of estimates of causal effects in small samples or when data are sparse. We demonstrate an approach to estimate the effect of environmental tobacco smoke on body mass index among children aged 4–9 years who were enrolled in a longitudinal birth cohort in New York, USA. We provide an algorithm and supply SAS and Stan code that can be adopted to implement this computational approach more generally.
SMMR Machine Learning · 发表于 2017-03-01
Grant B Weller, Jenna Lovely, David W Larson, Berton A Earnshaw, Marianne Huebner
摘要
Hospital-specific electronic health record systems are used to inform clinical practice about best practices and quality improvements. Many surgical centers have developed deterministic clinical decision rules to discover adverse events (e.g. postoperative complications) using electronic health record data. However, these data provide opportunities to use probabilistic methods for early prediction of adverse health events, which may be more informative than deterministic algorithms. Electronic health record data from a set of 9598 colorectal surgery cases from 2010 to 2014 were used to predict the occurrence of selected complications including surgical site infection, ileus, and bleeding. Consistent with previous studies, we find a high rate of missing values for both covariates and complication information (4–90%). Several machine learning classification methods are trained on an 80% random sample of cases and tested on a remaining holdout set. Predictive performance varies by complication, although an area under the receiver operating characteristic curve as high as 0.86 on testing data was achieved for bleeding complications, and accuracy for all complications compares favorably to existing clinical decision rules. Our results confirm that electronic health records provide opportunities for improved risk prediction of surgical complications; however, consideration of data quality and consistency standards is an important step in predictive modeling with such data.
SMMR Clinical Trials · 发表于 2017-03-01
Wenfu Xu, Feifang Hu, Siu Hung Cheung
摘要
The increase in the popularity of non-inferiority clinical trials represents the increasing need to search for substitutes for some reference (standard) treatments. A new treatment would be preferred to the standard treatment if the benefits of adopting it outweigh a possible clinically insignificant reduction in treatment efficacy (non-inferiority margin). Statistical procedures have recently been developed for treatment comparisons in non-inferiority clinical trials that have multiple experimental (new) treatments. An ethical concern for non-inferiority trials is that some patients undergo the less effective treatments; this problem is more serious when multiple experimental treatments are included in a balanced trial in which the sample sizes are the same for all experimental treatments. With the aim of giving fewer patients the inferior treatments, we propose a response-adaptive treatment allocation scheme that is based on the doubly adaptive biased coin design. The proposed adaptive design is also shown to be superior to the balanced design in terms of testing power.
SiM Missing Data & Measurement Error Diagnostics & Prediction · 发表于 2017-02-28
Matthew Zawistowski, Jeremy B. Sussman, Timothy P. Hofer, Douglas Bentley, Rodney A. Hayward, Wyndy L. Wiitala
摘要
Creating accurate risk prediction models from Big Data resources such as Electronic Health Records (EHRs) is a critical step toward achieving precision medicine. A major challenge in developing these tools is accounting for imperfect aspects of EHR data, particularly the potential for misclassified outcomes. Misclassification, the swapping of case and control outcome labels, is well known to bias effect size estimates for regression prediction models. In this paper, we study the effect of misclassification on accuracy assessment for risk prediction models and find that it leads to bias in the area under the curve (AUC) metric from standard ROC analysis. The extent of the bias is determined by the false positive and false negative misclassification rates as well as disease prevalence. Notably, we show that simply correcting for misclassification while building the prediction model is not sufficient to remove the bias in AUC. We therefore introduce an intuitive misclassification-adjusted ROC procedure that accounts for uncertainty in observed outcomes and produces bias-corrected estimates of the true AUC. The method requires that misclassification rates are either known or can be estimated, quantities typically required for the modeling step. The computational simplicity of our method is a key advantage, making it ideal for efficiently comparing multiple prediction models on very large datasets. Finally, we apply the correction method to a hospitalization prediction model from a cohort of over 1 million patients from the Veterans Health Administrations EHR. Implementations of the ROC correction are provided for Stata and R. Published 2017. This article is a U.S. Government work and is in the public domain in the USA. *(abstract via PubMed)*
Biometrika Other · 发表于 2017-02-28
Qian Xiao, Hongquan Xu
摘要
Maximin distance Latin hypercube designs are widely used in computer experiments, yet their construction is challenging. Based on number theory and finite fields, we propose three algebraic methods to construct maximin distance Latin squares as special Latin hypercube designs. We develop lower bounds on their minimum distances. The resulting Latin squares and related Latin hypercube designs have larger minimum distances than existing ones, and are especially appealing for high-dimensional applications. *(abstract via OpenAlex)*
SMMR Testing & Uncertainty Diagnostics & Prediction Clinical Trials · 发表于 2017-02-27
Nancy A Obuchowski, Jennifer Bullen
摘要
Introduction: Quantitative imaging biomarkers (QIBs) are being increasingly used in medical practice and clinical trials. An essential first step in the adoption of a quantitative imaging biomarker is the characterization of its technical performance, i.e. precision and bias, through one or more performance studies. Then, given the technical performance, a confidence interval for a new patient’s true biomarker value can be constructed. Estimating bias and precision can be problematic because rarely are both estimated in the same study, precision studies are usually quite small, and bias cannot be measured when there is no reference standard. Methods: A Monte Carlo simulation study was conducted to assess factors affecting nominal coverage of confidence intervals for a new patient’s quantitative imaging biomarker measurement and for change in the quantitative imaging biomarker over time. Factors considered include sample size for estimating bias and precision, effect of fixed and non-proportional bias, clustered data, and absence of a reference standard. Results: Technical performance studies of a quantitative imaging biomarker should include at least 35 test–retest subjects to estimate precision and 65 cases to estimate bias. Confidence intervals for a new patient’s quantitative imaging biomarker measurement constructed under the no-bias assumption provide nominal coverage as long as the fixed bias is <12%. For confidence intervals of the true change over time, linearity must hold and the slope of the regression of the measurements vs. true values should be between 0.95 and 1.05. The regression slope can be assessed adequately as long as fixed multiples of the measurand can be generated. Even small non-proportional bias greatly reduces confidence interval coverage. Multiple lesions in the same subject can be treated as independent when estimating precision. Conclusion: Technical performance studies of quantitative imaging biomarkers require moderate sample sizes in order to provide robust estimates of bias and precision for constructing confidence intervals for new patients. Assumptions of linearity and non-proportional bias should be assessed thoroughly.
SiM Survival Analysis Nonparametric & Semiparametric · 发表于 2017-02-27
Yanqin Feng, Ran Duan, Jianguo Sun
摘要
Nonparametric comparison of survival functions is one of the most commonly required task in failure time studies such as clinical trials, and for this, many procedures have been developed under various situations. This paper considers a situation that often occurs in practice but has not been discussed much: the comparison based on interval-censored data in the presence of unequal censoring. That is, one observes only interval-censored data, and the distributions of or the mechanisms behind censoring variables may depend on treatments and thus be different for the subjects in different treatment groups. For the problem, a test procedure is developed that takes into account the difference between the distributions of the censoring variables, and the asymptotic normality of the test statistics is given. For the assessment of the performance of the procedure, a simulation study is conducted and suggests that it works well for practical situations. An illustrative example is provided. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Longitudinal Data Latent Variables & Mixtures Causal Inference · 发表于 2017-02-27
Brisa N. Sánchez, Sehee Kim, Mary D. Sammel
摘要
Latent variable (LV) models are increasingly being used in environmental epidemiology as a way to summarize multiple environmental exposures and thus minimize statistical concerns that arise in multiple regression. LV models may be especially useful when multivariate exposures are collected repeatedly over time. LV models can accommodate a variety of assumptions but, at the same time, present the user with many choices for model specification particularly in the case of exposure data collected repeatedly over time. For instance, the user could assume conditional independence of observed exposure biomarkers given the latent exposure and, in the case of longitudinal latent exposure variables, time invariance of the measurement model. Choosing which assumptions to relax is not always straightforward. We were motivated by a study of prenatal lead exposure and mental development, where assumptions of the measurement model for the time-changing longitudinal exposure have appreciable impact on (maximum-likelihood) inferences about the health effects of lead exposure. Although we were not particularly interested in characterizing the change of the LV itself, imposing a longitudinal LV structure on the repeated multivariate exposure measures could result in high efficiency gains for the exposure-disease association. We examine the biases of maximum likelihood estimators when assumptions about the measurement model for the longitudinal latent exposure variable are violated. We adapt existing instrumental variable estimators to the case of longitudinal exposures and propose them as an alternative to estimate the health effects of a time-changing latent predictor. We show that instrumental variable estimators remain unbiased for a wide range of data generating models and have advantages in terms of mean squared error. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Other · 发表于 2017-02-27
Jongho Im, Eunyong Ahn, Namseon Beck, Jae Kwang Kim, Taesung Park
摘要
Correlation coefficient estimates are often attenuated for truncated samples in the sense that the estimates are biased towards zero. Motivated by real data collected in South Sudan, we consider correlation coefficient estimation with singly truncated bivariate data. By considering a linear regression model in which a truncated variable is used as an explanatory variable, a consistent estimator for the regression slope can be obtained from the ordinary least squares method. A consistent estimator of the correlation coefficient is then obtained by multiplying the regression slope estimator by the variance ratio of the two variables. Results from two limited simulation studies confirm the validity and robustness of the proposed method. The proposed method is applied to the South Sudanese children's anthropometric and nutritional data collected by World Vision. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
Biometrika Spatial & Time Series · 发表于 2017-02-27
W. Ehm, E. Y. Ovcharov
摘要
Decompositions of the score of a forecast represent useful tools for assessing its performance. We consider local score decompositions permitting detailed forecast assessments across a spectrum of conditions of interest. We derive corrections to the bias of the decomposition components in the framework of point forecasts of quantile-type functionals, and illustrate their performance by simulation. Related bias corrections have thus far only been known for squared error criteria. *(abstract via OpenAlex)*
SMMR Causal Inference Machine Learning Econometrics & Economics · 发表于 2017-02-27
Jiaqi Li, Anil Vachani, Andrew Epstein, Nandita Mitra
摘要
Estimation of common cost–effectiveness measures, including the incremental cost–effectiveness ratio and the net monetary benefit, is complicated by the need to account for informative censoring and inherent skewness of the data. In addition, since the two components of these measures, medical costs and survival are often collected from observational claims data, one must account for potential confounders. We propose a novel doubly robust, unbiased estimator for cost–effectiveness based on propensity scores that allow the incorporation of cost history and time-varying covariates. Further, we use an ensemble machine learning approach to obtain improved predictions from parametric and non-parametric cost and propensity score models. Our simulation studies demonstrate that the proposed doubly robust approach performs well even under mis-specification of either the propensity score model or the outcome model. We apply our approach to a cost–effectiveness analysis of two competing lung cancer surveillance procedures, CT vs. chest X-ray, using SEER-Medicare data.
SiM Survival Analysis · 发表于 2017-02-26
Leyla Azarang, Thomas Scheike, Jacobo de Uña-Álvarez
摘要
In this work, we present direct regression analysis for the transition probabilities in the possibly non-Markov progressive illness-death model. The method is based on binomial regression, where the response is the indicator of the occupancy for the given state along time. Randomly weighted score equations that are able to remove the bias due to censoring are introduced. By solving these equations, one can estimate the possibly time-varying regression coefficients, which have an immediate interpretation as covariate effects on the transition probabilities. The performance of the proposed estimator is investigated through simulations. We apply the method to data from the Registry of Systematic Lupus Erythematosus RELESSER, a multicenter registry created by the Spanish Society of Rheumatology. Specifically, we investigate the effect of age at Lupus diagnosis, sex, and ethnicity on the probability of damage and death along time. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Survival Analysis · 发表于 2017-02-26
Ying Wu, Richard J. Cook
摘要
A model is developed for chronic diseases with an indolent phase that is followed by a phase with more active disease resulting in progression and damage. The time scales for the intensity functions for the active phase are more naturally based on the time since the start of the active phase, corresponding to a semi-Markov formulation. This two-phase model enables one to fit a separate regression model for the duration of the indolent phase and intensity-based models for the more active second phase. In cohort studies for which the disease status is only known at a series of clinical assessment times, transition times are interval-censored, which means the time origin for phase II is interval-censored. Weakly parametric models with piecewise constant baseline hazard and rate functions are specified, and an expectation-maximization algorithm is described for model fitting. Simulation studies examining the performance of the proposed model show good performance under maximum likelihood and two-stage estimation. An application to data from the motivating study of disease progression in psoriatic arthritis illustrates the procedure and identifies new human leukocyte antigens associated with the duration of the indolent phase. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*
SiM Survival Analysis Latent Variables & Mixtures · 发表于 2017-02-24
M. Rowley, H. Garmo, M. Van Hemelrijck, W. Wulaningsih, B. Grundmark, B. Zethelius, N. Hammar, G. Walldius, M. Inoue, L. Holmberg, A.C.C. Coolen
摘要
Survival data analysis becomes complex when the proportional hazards assumption is violated at population level or when crude hazard rates are no longer estimators of marginal ones. We develop a Bayesian survival analysis method to deal with these situations, on the basis of assuming that the complexities are induced by latent cohort or disease heterogeneity that is not captured by covariates and that proportional hazards hold at the level of individuals. This leads to a description from which risk-specific marginal hazard rates and survival functions are fully accessible, 'decontaminated' of the effects of informative censoring, and which includes Cox, random effects and latent class models as special cases. Simulated data confirm that our approach can map a cohort's substructure and remove heterogeneity-induced informative censoring effects. Application to data from the Uppsala Longitudinal Study of Adult Men cohort leads to plausible alternative explanations for previous counter-intuitive inferences on prostate cancer. The importance of managing cardiovascular disease as a comorbidity in women diagnosed with breast cancer is suggested on application to data from the Swedish Apolipoprotein Mortality Risk Study. Copyright © 2017 John Wiley & Sons, Ltd. *(abstract via PubMed)*